LincRNA‐EPS inhibits caspase‐11 and NLRP3 inflammasomes in gingival fibroblasts to alleviate periodontal inflammation
Cell Proliferation · 2024
DOI: 10.1111/cpr.13539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2024. Verfasst von Anni Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics, Stomatological Hospital and Dental School of Tongji University, Shanghai Engineering Research Center of Tooth Restorati…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Periodontitis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
To investigate the effects of long intergenic noncoding RNA‐erythroid prosurvival (lincRNA‐EPS) on periodontal inflammation mediated by inflammasomes and to explore its mechanism. Experimental periodontitis was induced in KO ( lincRNA‐EPS −/− ) and WT ( lincRNA‐EPS +/+ ) mice to compare the periodontal bone loss and inflammation by using micro‐computed tomography, immunofluorescence staining and haematoxylin and eosin staining. The expression and activation of cysteinyl aspartate‐specific proteinase‐11 (caspase‐11) and NOD‐like receptor protein 3 (NLRP3) inflammasomes, as well as nuclear factor‐kappa B (NF‐κB) activation in mouse gingival fibroblasts (MGFs), were measured by real‐time quantitative polymerase chain reaction, Western blotting, enzyme‐linked immunosorbent and lactate dehydrogenase assays. MGFs were transfected with overexpression plasmids to assess the biological functions of lincRNA‐EPS. RNA pull‐down and immunoprecipitation experiments were performed to identify the interacting protein of lincRNA‐EPS. LincRNA‐EPS‐expressing lentivirus was locally administered to inflamed periodontal tissues to evaluate its salvage function in periodontitis. The absence of lincRNA‐EPS increased bone loss and expression of myeloperoxidase, interleukin‐1α (IL‐1α) and IL‐1β in the inflammatory periodontium. LincRNA‐EPS KO MGFs exhibited increased expression and activation of caspase‐11/NLRP3 inflammasome components than WT MGFs under lipopolysaccharide (LPS) stimulation. The expression and activation of these molecules were inhibited in lincRNA‐EPS overexpressed MGFs. Mechanistically, lincRNA‐EPS directly bound to transactive response DNA‐binding protein 43 (TDP43) in the nucleus of MGFs, and TDP43 knockdown exerted a similar inhibitory effect on NF‐κB activation and the inflammasomes as lincRNA‐EPS overexpression. Locally injecting lincRNA‐EPS‐expressing lentivirus weakened the periodontal damage. LincRNA‐EPS inhibits the LPS‐induced production and activation of caspase‐11 and NLRP3 inflammasomes by suppressing the activation of the NF‐κB signalling pathway via interacting with TDP43, thereby alleviating periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Prosthodontics, Stomatological Hospital and Dental School of Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China.
ORCID-Profile: Anni Hu
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Hu, A., Xiao, F., Wu, W., Xu, H., & Su, J. (2024). LincRNA‐EPS inhibits caspase‐11 and NLRP3 inflammasomes in gingival fibroblasts to alleviate periodontal inflammation. Cell Proliferation. https://doi.org/10.1111/cpr.13539
Vancouver
Hu A, Xiao F, Wu W, Xu H, Su J. LincRNA‐EPS inhibits caspase‐11 and NLRP3 inflammasomes in gingival fibroblasts to alleviate periodontal inflammation. Cell Proliferation. 2024. doi:10.1111/cpr.13539
BibTeX
@article{Hu2024,
author = {Hu, Anni and Xiao, Fan and Wu, Wenjing and Xu, Huilin and Su, Jiansheng},
title = {LincRNA‐EPS inhibits caspase‐11 and NLRP3 inflammasomes in gingival fibroblasts to alleviate periodontal inflammation},
journal = {Cell Proliferation},
year = {2024},
doi = {10.1111/cpr.13539}
}
EUVIMED